Startup EQRx is taking on high-price prescription drugs with plans to bring ‘me too’ drugs to market at as little as one-third to one-fifth the price of their rivals. Photo: Mark Hertzberg/Zuma Press By Joseph Walker Joseph Walker The Wall Street Journal Biography @joewalkerWSJ joseph.walker@wsj.com Jan. 12, 2020 10:14 am ET A startup pharmaceuticals company… Read More »
Dive Brief: For-profit hospital operator Community Health Systems posted a wider net loss of $ 167 million on revenues of $ 3.3 billion in the second quarter of 2019.That’s a 7.3% decrease in revenue year over year from $ 3.56 billion in 2018, but slightly higher than Wall Street expectations. On a somewhat brighter note… Read More »
Alfonso Cuarón Is Roma about to hit The Wall? At the moment, it certainly looks that way, and a collision could mean yet another headache for the Oscars. With 10 Oscar nominations and an often-predictive Critics Choice award under its belt, Alfonso Cuaron’s Netflix drama about a housekeeper in Mexico City appears to be holding… Read More »
In October 2017, President Trump declared the opioid crisis a national public-health emergency. Now his fight over the border wall, which he has in part justified on stopping drugs, is a harmful distraction from that very real problem facing the country. According to statistics released by the National Institute on Drug Abuse, there were 72,306… Read More »